Jacobs Levy Equity Management
LOGC

Jacobs Levy Equity Management’s LogicBio Therapeutics, Inc. Common Stock LOGC Stock Holding History

Jacobs Levy Equity Management’s Portfolio LOGC Stock Details LOGC Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
2020
Q4 		$154K Sell
2020
Q3 		$574K Buy
2020
Q2 		$97K Buy